Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a): Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04138043).
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran: primary endpoint results, effect…
- Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD: primary endpoint results, effect estimate with…
- Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer: primary endpoint results, effect estimate with confidence…
- Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801): Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00541775).
- Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN): Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00612105).
- Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD: Complete Statistical AnalysisIndependent statistical analysis of Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SAFOIndependent statistical analysis of Orthotics in Ambulatory Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01527162).
- SAFRIndependent statistical analysis of Social Workers Addressing Firearm Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05784662).
- SaFTiEIndependent statistical analysis of The Sleep and Teamwork in EMS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04456764).
- SAGB-PMIndependent statistical analysis of Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543140).
- SAGEIndependent statistical analysis of Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02539459).
- SAGEIndependent statistical analysis of Effect of a Two-month Carbohydrate-restricted Diet on Energy Metabolism in a Seniors' Residence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SAHA + CHOP in Untreated T-cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00787527).
- SAIA-HTNIndependent statistical analysis of Systems Analysis and Improvement Approach for the Hypertension Care Cascade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04088656).
- SAILIndependent statistical analysis of Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SAILIndependent statistical analysis of Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01687179).
- SAILIndependent statistical analysis of Sustained Aeration of Infant Lungs Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139800).
- SAKURAIndependent statistical analysis of Study to Investigate the Efficacy of Symbicort® SMART.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00839800).
- SALIFIndependent statistical analysis of A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment: primary endpoint results,…
- Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SALPIndependent statistical analysis of Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Salsalate as an Adjunctive Treatment for Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Salsalate as an Adjunctive Treatment for Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578486).
- Salsalate for Insulin Resistance in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Salsalate for Insulin Resistance in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182727).
- SALTIndependent statistical analysis of Isotonic Solution Administration Logistical Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345486).
- SALTIndependent statistical analysis of Steroids After Laser Trabeculoplasty for Glaucoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00981435).
- Salt to GrowIndependent statistical analysis of Physiologic Approach to Sodium Supplementation in Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03889197).
- SALUDIndependent statistical analysis of Self-Administered Lidocaine Gel for Pain Management With IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02738203).
- SAMIndependent statistical analysis of Sensory Augmentation Methods in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03988400).
- SAMIndependent statistical analysis of Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SAMBAIndependent statistical analysis of Severe Asthma, MepolizumaB and Affect: SAMBA Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04680611).
- Same Day Discharge After Minimally-invasive Sacrocolpopexy: Complete Statistical AnalysisIndependent statistical analysis of Same Day Discharge After Minimally-invasive Sacrocolpopexy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03730103).
- SAMMPRISIndependent statistical analysis of Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SAMSIndependent statistical analysis of Supervised Asthma Medication in Schools (SAMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01997463).
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial: Complete Statistical AnalysisIndependent statistical analysis of Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01178827).
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial: Complete Statistical AnalysisIndependent statistical analysis of Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00863551).